India's Supreme Court, in a landmark judgment on March 9, 2018, recognized and legalized passive euthanasia, specifically through the mechanism of "living wills" or "advance medical directives." This decision, delivered by a five-judge Constitution Bench, upheld an individual's right to die with dignity as an integral part of the fundamental right to life under Article 21 of the Indian Constitution, marking a significant shift in the nation's legal and ethical landscape concerning end-of-life care.

The ruling came in response to a petition filed by the non-governmental organization Common Cause, which sought to establish a legal framework for individuals to refuse medical treatment in advance, should they enter an irreversible vegetative state or suffer from a terminal illness with no hope of recovery. The court differentiated passive euthanasia, which involves withdrawing life support or foregoing medical intervention, from active euthanasia, where a deliberate act is taken to end a life. Active euthanasia remains illegal in India.

In its 2018 judgment, the Supreme Court established stringent guidelines and safeguards to prevent misuse of living wills, emphasizing the need to protect vulnerable individuals. These initial guidelines mandated a multi-tiered approval process involving medical boards and a Judicial Magistrate First Class (JMFC) to ascertain the authenticity of the living will and the patient's irreversible condition before discontinuing life support.

However, over time, the implementation of these elaborate procedures proved challenging, leading to practical difficulties for patients and their families seeking to exercise this right. Recognizing these impediments, the Supreme Court revisited the issue. On February 3, 2023, the bench, comprising Justices K.M. Joseph and Aniruddha Bose, among others, modified and simplified the 2018 guidelines. The primary aim was to streamline the process for executing and acting upon living wills, making the exercise of the right more accessible while retaining essential safeguards.

Key modifications introduced in the 2023 judgment include:

  • Reduced Judicial Scrutiny: The requirement for the Judicial Magistrate First Class (JMFC) to countersign the living will at the time of its execution was removed. Instead, the will must be attested by two independent witnesses and a gazetted officer or a notary public.
  • Simplified Medical Board Process: When a patient's condition necessitates acting on a living will, the primary certifying medical board can now consist of the treating physician and at least two other registered medical practitioners with at least five years of experience in the relevant specialty.
  • Reduced District Collector Involvement: The role of the District Collector was modified, reducing some procedural burdens while ensuring oversight.
  • Expedited Review: The time frame for the medical boards to confirm the patient's irreversible condition and the authenticity of the living will was clarified to ensure timely decision-making.

These modifications aim to balance individual autonomy with the need for robust oversight, ensuring that the process is both practical and ethically sound. The Supreme Court's decisions in 2018 and 2023 collectively represent a progressive stance on patient rights and end-of-life decisions, providing a legal pathway for individuals to determine their fate with dignity in terminal medical situations. The framework is expected to continue evolving as medical advancements and societal discussions progress.